Phenotypes associated with this allele
|
|
| Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Agrptm2(HBEGF)Rpa mutation
(1 available);
any
Agrp mutation
(18 available)
|
|
|
behavior/neurological
|
|
• following treatment with diptheria toxin (DT) to specifically ablate NPY-expressing cells, mice fail to increase their food intake at a 10% loss of body weight and their intake dramatically decreased as their weight loss approaches 20%
|
|
|
| Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Agrptm2(HBEGF)Rpa mutation
(1 available);
any
Agrp mutation
(18 available)
|
|
|
mortality/aging
|
|
• adult mice injected intramuscularly with diptheria toxin (DT) to specifically ablate NPY-expressing cells exhibit a greater than 80% drop in feeding, a 20% reduction in their body weight and have to be euthanized unlike similarly treated wild-type mice
• however, most mice survive when injected with DT as neonate or when receiving injections as neonate and adults
|
behavior/neurological
|
|
• adult mice injected intramuscularly with diptheria toxin (DT) to specifically ablate NPY-expressing cells exhibit increased water consumption compared to similarly treated wild-type mice
|
|
|
• adult mice injected intramuscularly with diptheria toxin (DT) to specifically ablate NPY-expressing cells exhibit a greater than 80% drop in feeding unlike similarly treated wild-type mice
• adults injected with DT cease to eat unlike similarly treated wild-type mice
• however, DT-treated mice are sustained by hand feeding via oral gavage with liquid food
|
growth/size/body
|
|
• adult mice injected intramuscularly with diptheria toxin (DT) to specifically ablate NPY-expressing cells exhibit 20% of their body weight unlike similarly treated wild-type mice
|
Allelic
Composition |
Agrptm2(HBEGF)Rpa/Agrp+
|
|
Genetic
Background |
involves: 129S4/SvJaeSor * C57BL/6 |
|
| Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Agrptm2(HBEGF)Rpa mutation
(1 available);
any
Agrp mutation
(18 available)
|
|
|
behavior/neurological
|
|
• adults injected with diptheria toxin (DT) to specifically ablate NPY-expressing cells cease to eat unlike similarly treated wild-type mice
• however, food consumption of neonates following injection with diptheria toxin to specifically ablate NPY-expressing cells is normal
|
growth/size/body
|
|
• neonates injection with diptheria toxin (DT) to specifically ablate NPY-expressing cells exhibit an 11% decreased in body weight at weaning compared to similarly treated wild-type mice
|
behavior/neurological
|
|
• diphtheria-treated mice bilaterally injected with a virus expressing a AAV1-CreGFP into the parabrachial nucleus
|
growth/size/body
|
|
• diphtheria-treated mice injected with a virus expressing a AAV1-CreGFP into the nucleus tractus solitaries or parabrachial nucleus prevents starvation induced by AgRP neuron ablation unlike in control mice
|
|
|
| Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Agrptm2(HBEGF)Rpa mutation
(1 available);
any
Agrp mutation
(18 available)
Tph2tm1Mscl mutation
(0 available);
any
Tph2 mutation
(41 available)
|
|
|
behavior/neurological
|
|
• in diphtheria-treated mice injected with a virus expressing a CAV2-cre into the nucleus tractus solitaries
|
growth/size/body
|
|
• diphtheria-treated mice injected with a virus expressing a CAV2-cre into the nucleus tractus solitaries prevents starvation induced by AgRP neuron ablation unlike in control mice
|
homeostasis/metabolism
|
|
| Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Agrptm2(HBEGF)Rpa mutation
(1 available);
any
Agrp mutation
(18 available)
Slc17a6tm1.1Thna mutation
(0 available);
any
Slc17a6 mutation
(59 available)
|
|
|
growth/size/body
|
|
• diphtheria-treated mice injected with a virus expressing a AAV1-CreGFP into the nucleus tractus solitaries or parabrachial nucleus prevents starvation induced by AgRP neuron ablation unlike in control mice
|
|
|
• mice injected with a virus expressing a AAV1-CreGFP into the parabrachial nucleus without ablation of AgRP neurons
|
behavior/neurological
|
|
• mice injected with a virus expressing a AAV1-CreGFP into the parabrachial nucleus whether treated with diphtheria or not
• in diphtheria treated mice bilaterally with a virus expressing a AAV1-CreGFP into the nucleus tractus solitaries
|
mortality/aging
|
|
• young adult mice stop eating and would succumb following treatment with diptheria toxin
• older moderately obese (35-40 g) mice survive diptheria toxin treatment despite weight loss
• however, mice that weigh over 40 g succumb following treatment with diptheria toxin
• norepinephrine treatment prevents prolongs the survival of diptheria toxin treated mice that weigh over 40 g
|
nervous system
|
|
• loss of agouti-related protein expressing neurons following treatment with diptheria toxin
|
behavior/neurological
|
|
• following treatment with diptheria toxin young adult mice gradually stop eating by day 6 post treatment
• older, moderately obese mice that are able to survive the weight loss resume feeding about 18 days after treatment
|
growth/size/body
|
|
• diptheria toxin treated older moderately obese mice weigh less than saline treated controls for several months after treatment
|
|
|
• following treatment with diptheria toxin mice lose 20% of their body weight
|
homeostasis/metabolism
reproductive system
|
|
• following diptheria toxin treatment of older moderately obese mice, both males and females become fertile, unlike saline treated mice which remain infertile
|
|
|
| Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Agrptm2(HBEGF)Rpa mutation
(1 available);
any
Agrp mutation
(18 available)
Tg(Pomc-EGFP)1Low mutation
(1 available)
|
|
|
growth/size/body
|
|
• adult mice treated with diptheria toxin (DT) to specifically ablate NPY-expressing cells exhibit 20% of their body weight unlike similarly treated wild-type mice
|
nervous system
|
|
• mice treated with diptheria toxin (DT) to specifically ablate NPY-expressing cells exhibit miniature inhibitory postsynaptic currents that are 6-fold lower than in wild-type mice and lower than in fasted wild-type mice
|
behavior/neurological
|
|
• in mice treated with diptheria toxin (DT) to specifically ablate NPY-expressing cells
|
growth/size/body
|
|
• in mice treated with diptheria toxin (DT) to specifically ablate NPY-expressing cells
|
Analysis Tools